Table 1. Demographics of subjects used for bladder cancer urine biomarker studies.
| Subjects Used for Luminex Based Screen of Urine Biomarkers | ||||||
|---|---|---|---|---|---|---|
| Variable | Category | Controls (N = 31) | Ta (N = 7) | Tis (N = 9) | T1 (N = 8) | T2–T4 (N = 11) |
| Age (years) | 65.93 ± 9.77 | 70.29 ± 9.82 | 71.00 ± 6.06 | 68.75 ± 7.24 | 74.45 ± 7.60 | |
| Gender, n (%) | Male | 28 (90.32%) | 5 (71.43%) | 9 (100.00%) | 7 (87.50%) | 11 (100.00%) |
| Female | 3 (9.68%) | 2 (28.57%) | 0 (0.00%) | 1 (12.50%) | 0 (0.00%) | |
| Race; n (%) | African American | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Asian | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | |
| Caucasian | 31 (100.00%) | 7 (100.00%) | 9 (100.00%) | 8 (100.00%) | 11 (100.00%) | |
| Hispanic | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | |
| Subjects Used for ELISA Validation of Urine Biomarkers | ||||||
| Controls (N = 20) | Ta (N = 35) | Tis (N = 5) | T1 (N = 8) | T2–T4 (N = 12) | ||
| Age (years) | 68.5 ± 11.4 | 67.6 ± 12.2 | 68.8 ± 3.7 | 74.375 ± 6.1 | 71.9 ± 11.2 | |
| Gender, n (%) | Male | 17 (85%) | 26 (74.3%) | 5 (100%) | 5 (62.5%) | 11 (91.6%) |
| Female | 3 (15%) | 9 (25.7%) | 0 (0.0%) | 3 (37.5%) | 1 (8.33%) | |
| Race, n (%) | African American | 3 (15%) | 2 (5.7%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Hispanic | 1 (5%) | 3 (8.6%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
| Latin America | 1 (5%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
| Caucasian | 14 (70%) | 30 (85.7%) | 5 (100%) | 8 (100%) | 12 (100%) | |
| Other | 1 (5%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
Data are presented as n (%) or average ± SD as appropriate. The T2–T4 group included 8 patients with T2, 2 with T3 and 2 with T4 BC. The controls comprised of urology clinic controls, without any urological cancers.